Working… Menu

A Study of ADI-001 in B Cell Malignancies (GLEAN-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04735471
Recruitment Status : Recruiting
First Posted : February 3, 2021
Last Update Posted : June 4, 2021
Information provided by (Responsible Party):
Adicet Bio, Inc

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 31, 2023
Estimated Study Completion Date : March 31, 2024